Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Common genetic variation in obesity, lipid transfer genes and risk of Metabolic Syndrome: Results from IDEFICS/I.Family study and meta-analysis


As the prevalence of metabolic syndrome (MetS) in children and young adults is increasing, a better understanding of genetics that underlie MetS will provide critical insights into the origin of the disease. We examined associations of common genetic variants and repeated MetS score from early childhood to adolescence in a pan-European, prospective IDEFICS/I.Family cohort study with baseline survey and follow-up examinations after two and six years. We tested associations in 3067 children using a linear mixed model and confirmed the results with meta-analysis of identified SNPs. With a stringent Bonferroni adjustment for multiple comparisons we obtained significant associations(p < 1.4 × 10−4) for 5 SNPs, which were in high LD (r2 > 0.85) in the 16q12.2 non-coding intronic chromosomal region of FTO gene with strongest association observed for rs8050136 (effect size(β) = 0.31, pWald = 1.52 × 10−5). We also observed a strong association of rs708272 in CETP with increased HDL (p = 5.63 × 10−40) and decreased TRG (p = 9.60 × 10−5) levels. These findings along with meta-analysis advance etiologic understanding of childhood MetS, highlighting that genetic predisposition to MetS is largely driven by genes of obesity and lipid metabolism. Inclusion of the associated genetic variants in polygenic scores for MetS may prove to be fundamental for identifying children and subsequently adults of the high-risk group to allow earlier targeted interventions.


A collection of risk factors, including central obesity, insulin resistance, dyslipidemia, and hypertension, describes metabolic syndrome (MetS). Additionally, MetS is a known precursor in cardiovascular disease development1. MetS has become a major public health concern globally due to its increasing prevalence and association with various chronic diseases2. MetS etiology is quite complex, involving a strong interplay between multiple genetic, environmental and lifestyle-related factors. In European ancestry, the heritability of the MetS was estimated to be between 13–30%3,4. The early prognosis of MetS is therefore extremely valuable for early detection of individuals at high genetic risk of developing the disease later in life and for encouraging change in lifestyle to reduce risk. While numerous single nucleotide polymorphisms (SNPs) associated with individual metabolic components and diseases have been reported in genome-wide association studies (GWAS)5,6,7,8, the effect of these polymorphisms on the MetS network and related diseases is not well studied.

Further, of all MetS components, lipid levels seem under higher genetic determination9. This has also been observed in the genetic association studies suggesting that genetic effects on lipid levels are more pronounced than for other traits10. Most of the genetic association studies for MetS have been conducted in adult population5,10,11 and are limited by the usage of one-point measurements7,12,13,14. As the prevalence of MetS in children and young adults is increasing15, a better understanding of the genetics that underlies MetS throughout childhood and adolescence will provide critical insights into the origin of the disease. We performed a longitudinal analysis using a repeated measurement design for the effect of genetic variants on a quantitative MetS score from early childhood to adolescence. We examined the association between 350 pre-selected variants and the MetS score derived from measured waist circumference (WC), high-density lipoprotein (HDL), homeostasis model assessment of insulin resistance (HOMA-IR), triglycerides (TRG), systolic blood pressure (SBP) and diastolic blood pressure (DBP) in a pan-European children cohort.


Study population

The study population was enrolled in a pan-European, multi-center, prospective IDEFICS/I.Family cohort across three-time points. The IDEFICS baseline survey included a population-based sample of 16,229 children aged 2 to 9.9 years from eight European countries (Belgium, Cyprus, Estonia, Germany, Hungary, Italy, Spain, and Sweden) who were examined the first time in 2007/2008. Follow-up examinations were conducted after two (T1) and six (T3, I.Family study) years16,17. In our longitudinal analysis using repeated measurement design, both baseline and follow-up data from the IDEFICS and I.Family study were included from all countries except Cyprus, for understanding the associations of genetic variants with MetS. In the IDEFICS/I.Family study, risk factors of lifestyle-related outcomes were investigated in young children and anthropometric and clinical examinations were conducted at each survey wave. Additionally, health characteristics and lifestyle behaviors were collected and biosamples were taken (Details in Supplementary methods). Parents gave written informed consent before study participation and children gave oral consent before the examinations. Ethical approval was obtained from the relevant local or national ethics committees by each of the study centers, namely from the Ethics Committee of the University Hospital Ghent (Belgium), the Tallinn Medical Research Ethics Committee of the National Institutes for Health Development (Estonia), the Ethics Committee of the University Bremen (Germany), the Scientific and Research Ethics Committee of the Medical Research Council Budapest (Hungary), the Ethics Committee of the Health Office Avellino (Italy), the Ethics Committee for Clinical Research of Aragon (Spain), and the Regional Ethical Review Board of Gothenburg (Sweden). We certify that all applicable institutional and governmental guidelines and regulations concerning the ethical use of human volunteers were followed during this research.

MetS Score

There are no universal definitions of MetS in children, we have, therefore, utilized a continuous MetS score as documented in a recent publication on the IDEFICS study. The MetS score was calculated summing age and sex-specific z-scores of WC, HOMA-IR, HDL, TRG, SBP, and DBP according to the following formula by Ahrens et al.18:


The components used to calculate the MetS score were based on the same risk factors used in the adult MetS definition. A higher score was associated with an unfavorable metabolic profile18. A detailed description of the measurements of components of MetS has been published previously18.

Genotyping and quality control of SNP data

Genomic DNA was extracted either from saliva or blood samples. Genotyping was conducted in two batches on 3492 children using the UK Biobank Axiom 196-Array from Affymetrix (Santa Clara, USA). We applied extensive quality control metrics to the data following the recommendations of Weale M19, based on which we excluded the following: SNPs with a call rate of less than 97.5%, failure to meet Hardy-Weinberg equilibrium at a p-value of less than 10−4, a minor allele frequency (MAF) of less than 0.5% (batch 1) and 0.08% (batch 2), samples with a call rate of less than 98% (batch 1) and 96% (batch 2), poor intensity, sex mismatch, anomalous high heterozygosity (cut-off of 3 standard deviations (SD) from mean), cryptic relatedness, no phenotypic information or as population outliers with any of a sample’s standardized principal component (PC) loading exceeds the interval mean ±3 SD19,20. We did quality control filtering using Affymetrix calling software APT and the R packages genABEL21 and SNPRelate22. A sample of 3067 children remained for further analyses. Genome-wide imputation was carried out using the Minimac3 v2.0.1 software and reference haplotypes from unrelated individuals from the 1000 Genomes Project phase III v5.

To address the issue of population stratification, we performed a principal components analysis using the SNPRelate v1.10.2 R package, where the eigenvectors or PCs are sorted in decreasing order of the corresponding eigenvalues. The first eigenvector (PC1) has the most variation in the data on the genetic matrix (SNP by sample); the second eigenvector (PC2) has the second-most, and so on. To account for relatedness in our sample, we calculated the genetic relatedness matrix (GRM) from the genotype data using the program EMMAX v20120210 ( The GRM matrix along with relatedness further adjusts for population stratification.

Selection of candidate SNPs

A custom panel of SNPs were selected for analysis in this study using the following three strategies: (a) SNPs significantly associated in previous GWAS studies (p < 5 × 10−8) with MetS were identified using NHGRI-EBI GWAS Catalog23 and PubMed search (n = 29); (b) All SNP from candidate studies which were significantly associated (p < 0.05) with MetS were included using SNP curator platform24 (n = 193); (c) genes associated with MetS (using DisGenet browser25) and involved in lipid metabolism pathway (CTdbase26) were uploaded into the Candidate gene SNP selection (Genepipe) pipeline of “SNPinfo” a web-based SNP selection tool27 with European study population. The algorithm used for selecting SNPs from the provided list of genes was as follows: five kb upstream and 1 kb downstream of the gene coordinate were included in the selection. SNPs showing a MAF of 0.05 or greater were included. Tagging proportion cut-off to filter a gene was kept at 0.8 and the linkage disequilibrium (LD) threshold cut off was kept at 0.8. The minimum number of SNPs tagged by a tag SNP was set to 3. To ensure that each gene has some coverage a minimum of 1 tag SNP to a maximum of 5 tag SNPs per gene were included. Further SNPs were filtered using the functional SNP prediction in “Genepipe” that causes an amino acid change or that may alter the functional or structural properties of the translated protein, disrupt transcription factor binding sites, disrupt splice sites or other functional sites. A total of 156 SNPs were identified using this strategy. Overall, we obtained 371 SNPs after removing duplicates among the three selection strategies, out of which we had genotyping data from 357 SNPs. After excluding 4 monomorphic SNPs and 3 SNPs due to quality control issues, the final analyses were carried out on 350 SNPs (n = 117 genotyped, n = 233 imputed).


We carried out a meta-analysis to review associations between FTO variants significantly associated in the present study (rs8050136, rs1121980, rs1558902, rs9939609, rs1421085) and MetS as the outcome. We systematically searched PubMed, Web of Science and Scopus and supplemented it by scanning reference lists of articles identified (including reviews) up to December 2019. The search strategy is detailed in Supplementary Methods. Studies were eligible for inclusion if they had met all of the following criteria: (1) provided additive odds ratios (ORs) or sufficient genotypic information for calculating ORs with 95% confidence intervals (CI); (2) were retrospective or prospective in design, and (3) were conducted in humans. Studies reporting on components of MetS alone were excluded from the analysis. For each study included, the following information was extracted: first author, year of publication, geographical location, study design, sample size, number of cases and controls, information on assay performed for genotyping, effect sizes, allele/genotypic frequency in cases and controls, and confounders adjusted for in reported associations. The quality of each included study was assessed using the Newcastle-Ottawa Scale for case-control studies28 which range from zero points (low quality) to nine points (high quality). If multiple publications on the same study data were available, the most up-to-date or comprehensive information was used. Methods and results are reported following the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA) guidelines29.

Statistical analysis

The characteristics of study participants were presented as means (± SD) for continuous variables and as frequencies (percentages) for categorical variables. Associations between SNPs and repeated MetS score values of non-independent individuals were analyzed using the Wald t-test with one degree of freedom applied on linear mixed models (LMM), using the R package GMMAT30 adjusting for age, sex, country of residence and the top five PCs as fixed effects, and using a kinship matrix to define the covariance structure of the random effect included in the model.

To account for multiple testing, we corrected the statistical significance level to α = 0.05/350 = 1.4 × 10−4 by the Bonferroni correction and false discovery rate (FDR) method for the 350 hypothesis tests. For further analysis, we presented results for only those SNPs that survived the FDR correction. We stratified association models by sex, controlling for age, country of residence, first five PCs and kinship matrix. Additionally, we performed conditional analyses on the FTO locus rs8050136 as a covariate. To identify the driving factor in the association of SNPs and MetS, we recalculated the LMM with each of the MetS components: WC, HOMA-IR, HDL, TRG, SBP, and DBP. Throughout, we used r² to report LD between pairs of SNPs. Quantile-quantile (Q-Q) plots and the genomic inflation factor (λ) were used to evaluate control of type I error. LocusZoom31 was used to plot regions harboring significant signals (p < 1.4 × 10−4) to visualize LD patterns. Statistical analyses were performed using R 3.5.3 and Stata 15. All statistical tests were 2- sided.

Functional annotation using existing datasets

To identify potential causal genes explaining the observed genetic associations with MetS, we searched for existing expression quantitative trait loci (eQTL) SNPs in the eQTL dataset GTEx V832. We estimated the associations between the identified lead SNP and transcript expression levels for genes within a +/− 1 Mb cis window around the transcription start site or a trans-gene.

In-silico functional analysis

We examined the potential functional significance of the SNPs that reached the significance level using the combined annotation-dependent depletion (CADD) method proposed by Kircher and colleagues33. CADD produces a single C score to measure the deleteriousness of a given variant, which will greatly improve in prioritizing the causal variants while conducting genetic analyses33. We also extracted the RegulomeDB score to describe the regulatory potential of these SNPs34.

Meta-analysis Crude ORs and 95% CIs in each study were estimated using a genetic additive model and evaluated for the strength of the associations between FTO variants and MetS risk. The study reported additive ORs were utilized when sufficient information on genotypic/allelic frequencies were not provided. Study-specific risk estimates were pooled by using random-effects meta-analyses and sensitivity analyses were performed using fixed-effect meta-analyses. To determine whether the genotypes in the control group deviated from Hardy-Weinberg Equilibrium (HWE) we used the R-package HardyWeinberg35. Heterogeneity was assessed using the standard χ2 tests and I2 statistic, where I2 > 50% indicated substantial heterogeneity36. Evidence of publication bias was sought using the Egger regression test for funnel asymmetry in addition to visual inspection of the funnel plots37,38. Two-sided P values <0.05 were considered statistically significant.


After quality control and analytical exclusions, we performed longitudinal analyses with genotypic information on 350 SNPs and repeated measures on study calculated MetS Scores from 3067 children at 3-time points (Fig. 1). Boys and girls were equally present in the analysis with a mean age of 6.20 (±1.77). Almost 5% of study participants were first degree relatives (Table 1).

Figure 1

Flowchart for inclusion/exclusion criteria.

Table 1 Study characteristics at baseline.

MetS score was not available for 314 study participants in any survey. In total, 2,753 children were utilized for the main analysis to test the association between pre-selected candidate SNPs and longitudinal MetS score; however, we made use of all children to test SNP effects on the components of the MetS score. Details of exclusions are shown in the appendix (Supplementary Table 1). A genomic control factor λ of 1.22 in the Q-Q plot of the association p-values suggested slight systematic inflation (Supplementary Fig. 1). The first five PCs explain only 1% of variance suggesting there may be no hidden pattern in the dataset (Supplementary Fig. 2).

Our results yielded significant associations for 13 SNPs with p-values corrected for FDR (Table 2). With a stringent Bonferroni adjustment for multiple comparisons, we obtained significant associations (p < 1.4 × 10−4) for 5 SNPs, which were highly correlated in the 16q12.2 chromosomal region in the non-coding intronic region of the FTO gene. The SNPs located in FTO gene were in high LD (r2 > 0.87), with the strongest association signal observed for rs8050136 (Pwald = 1.52 × 10−5) (Fig. 2). In LMMs conditioned on rs8050136, the risk of other variants in 16q12.2 was completely attenuated and non-significant (Supplementary Table 2). We could not replicate previously reported GWAS SNPs of MetS conducted on adults in the present children cohort (Supplementary Table 3). The allele frequencies reported in this study were comparable to those reported for European samples (Supplementary Table 4).

Table 2 Association of markers with longitudinal Metabolic Syndrome score in children of IDEFICS/I.Family study.
Figure 2

Regional association plot of markers with longitudinal metabolic syndrome score in children, recombination hotspots, and linkage disequilibrium heatmap for the 16q12.2 locus. −log10 of p values (left y-axis) drawn from the study participants of IDEFICS/I.Family cohort for a 500 kb region covering the entire FTO gene. The purple circle indicates the query variant (rs8050136). The LD estimates are color-coded as a heatmap from dark blue (0 ≥ r2 > 0.2) to red (0.8 ≥ r2 > 1.0). The bottom panel shows the genes and their orientation for each region. We based the association analysis on a one degree of freedom Wald t-test applied on linear mixed model, adjusted for age, sex, country of residence, first five principal components as fixed effects and kinship matrix to define the covariance structure of the random effect. The blue line represents the recombination rate (right y-axis) to estimate putative recombination hotspots across the region from HapMap.

Using data for additional covariates, we performed sex-specific analyses for SNPs that reached statistical significance (Table 3). The associations were stronger in boys compared to girls. We further went ahead to analyze the repeated measures of components of the MetS score as the outcome to understand which of the components drove the observed association. The variants in FTO were associated with higher SBP and larger WC whereas the variant A of rs708272 in CETP was strongly associated with decreased TRG levels and increased HDL levels (Supplementary Table 5).

Table 3 Association of markers with longitudinal Metabolic Syndrome stratified by sex.

A CADD-scaled C score of more than 10 for SNP rs8047395 (Supplementary Table 6) was observed in in-silico analyses. Similarly, a RegulomeDB score of four for three SNPs (rs8050136, rs1121980, and rs8044769; Supplementary Table 6) in the FTO gene was observed. Using existing eQTL datasets, we found that the rs8050136-A allele in muscle-skeletal tissue was associated with higher FTO gene expression based on the linear regression model.


We screened 193 records (Fig. 3) and identified 38 eligible studies39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77 for 5 FTO variants (8, 3, 3, 32, 10 studies for rs8050136, rs1121980, rs1558902, rs9939609 and rs1421085, respectively) on 80856 participants with 22462 cases and 58394 controls (Table 4). Including the present study there were 29760, 6343, 5532, 59411 and 9908 participants for rs8050136, rs1121980, rs1558902, rs9939609 and rs1421085 respectively. The control populations of the included studies were in HWE. In addition to ours, only 4 studies were conducted on children or adolescents. A forest plot of association of FTO variants with MetS is provided in Fig. 4. The OR for MetS and rs8050136, rs1121980, rs1558902, rs9939609 and rs1421085 was 1.17 (95% CI: 1.09–1.26), 1.14 (95% CI: 1.00–1.31), 1.26 (95% CI: 1.11–1.43), 1.14 (95% CI: 1.09–1.19) and 1.21 (95% CI: 1.08–1.35) respectively. The degree of between-study heterogeneity was least with I2 = 20.3% (P = 0.263) for rs8050136 and highest for rs1421085 with I2 = 53.5% (P = 0.018). Sensitivity analyses that used fixed-effect meta-analysis (rather than random-effects meta-analysis as in the primary analysis) yielded similar OR as random effect meta-analysis (Supplementary Fig. 3). There was no evidence for publication bias, as indicated by funnel plot analyses and Egger test for asymmetry (Supplementary Fig. 4).

Figure 3

Flow Diagram of Study Selection Process for Meta-analysis.

Table 4 Characteristics of studies included in the meta-analysis.
Figure 4

Forest plots of random effect meta-analysis of the association of FTO variants (rs8050136, rs1121980, rs1558902, rs9939609, rs1421085) with Metabolic Syndrome. CI = confidence interval. Sizes of data markers indicate the weight of each study in the analysis. Study-specific odds ratios were pooled using random-effects meta-analysis. Col, 2017; Dusatkova, 2013; Liem 2010; Zhao 2014 were conducted in the young population (age <18 years). Additive ORs were used as indicated in the study for Liem, 2010; Sjogren, 2008; Zhao; 2014.


Over the past decade, common genetic loci have been reported to be associated with MetS in different studies, mostly at a single time-point using a cross-sectional or a case-control approach7,76,78. Our study took a step ahead in investigating 350 pre-selected loci for their longitudinal association with a continuous MetS score during the transition from childhood to adolescence in a pan-European cohort of children with a follow-up period of up to seven years. We observed a strong association between common genetic variants in the FTO and longitudinal MetS score after Bonferroni correction for multiple comparisons. We observed stronger associations in boys as compared to girls. The effect sizes observed in our study on children were much larger than those reported in adults further suggesting greater genetic predisposition and lower influence from environmental and behavioral factors in youth.

The FTO gene codes for a nuclear protein of the non-haem iron and 2-oxoglutarate-dependent oxygenase superfamily, which is involved in posttranslational modification, DNA repair, and fatty acid metabolism79. FTO which is primarily expressed in the hypothalamus, plays a key role in energy homeostasis and regulation of food intake80. Even DNA methylation studies have shown an association with many pathological conditions including obesity81,82. FTO may thus play a role in metabolic regulation by altering gene expression in metabolically active tissues83. While the exact mechanism remains to be unraveled, it has been shown that genetic variants within the FTO gene are linked functionally to another obesity-related gene called IRX3, which promotes browning of white adipocytes, maybe a connecting link between FTO variants and obesity-related disorders76,84,85. Further, previous studies have observed that individuals homozygous for the risk alleles in FTO have impaired metabolic profile86,87,88. Similarly, our findings of the FTO association with MetS score may be related to its association with obesity89,90, T2DM91 and/or lipid abnormalities92,93. This is supported by the associations we observed between FTO variants and components of the MetS, particularly with WC and SBP. Various candidate gene studies have observed association between FTO variants and MetS in adults71,73,77,93 across different ethnicities73,76,93,94. Our results confirm the association of FTO variants and MetS in children and adolescent populations via its implication in the regulation of body fatness.

Though the CETP variant did not survive conservative Bonferroni correction, we observed a strong association of rs708272 with increased HDL (ß = 4.03, p = 5.63 × 10−40) and decreased TRG (ß = −2.43, p = 9.60 × 10−5) levels. Consistent to our observations previous literature has shown that some variants in the CETP gene, an essential protein of reverse cholesterol transport process are associated with decreased plasma CETP protein activity and protein levels, culminating in higher concentrations of HDL95,96 and reduced concentrations of TRG13. Similarly, meta-analyses have shown that carriers of the T allele, associated with lower CETP, have higher HDL concentrations than CC homozygotes97 and thereby showing an inverse association with MetS. Further, rs708272 of the CETP gene was moderately correlated (r2 = 0.47, MAF = 0.41) with the GWAS-identified SNP rs17353910, a less common SNP (MAF = 0.30) which could not be detected in the present study given the moderate sample size. We observed a significant association of rs708272 with MetS score after adjusting for BMI z-scores (Supplementary Table 7), suggesting that the association may partly be driven by lipid metabolism in addition to obesity.

In-silico examinations of the possible functional significance of SNPs found in our sample suggested that the FTO gene had a CADD C score of over 10 for one SNP. Likewise, the RegulomeDB score of 4 in the FTO gene for three SNPs suggests that transcription factor binding could be impaired by these SNPs., thus indicating that one or more variants in the FTO gene are likely to have a functional effect. Analysis of the eQTL showed that the rs8050136-A allele may upregulate the level of FTO gene expression in the muscle-skeletal tissue. However, to establish the biological function of these variants of susceptibility, more functional work is needed.

To further assess whether the MetS score association results vary by sex, we performed stratified analysis. The associations remained significant for both boys and girls with slightly stronger associations observed in boys. This is obvious as MetS is more common in adult males as compared to adult females in Europeans and other high-income countries98. A possible explanation could be due to the sex-modulated fat distribution interactions with the dynamics of cardiometabolic risk99.

In recent years there has been no meta-analysis on the FTO variants and MetS94,100,101,102, therefore the present meta-analysis provides an updated overview of the risk associated with variants in 16q12.2 involving data from 38 studies on 80856 participants plus the present IDEFICS/I.Family study. Pooled estimates from the meta-analysis further confirmed our findings for rs8050136, rs1121980, rs1558902, rs9939609, rs1421085 and MetS risk. Again, most of the studies in the meta-analysis were conducted on adults which may not be an appropriate extrapolation to children, given its greater impact in children compared to adults103.

Strengths of our study include the design (samples derived from a well-phenotyped cohort of children), an accurate and highly standardized outcome measurement, and the ability to include several important covariates. To our knowledge, this is the first study to report common genetic variation conferring MetS risk with longitudinal analysis in children104. The study could have benefitted further by in-depth laboratory functional assays, but this was beyond the scope of this paper. We therefore conducted an in-silico functional analysis. Though the study was adequately powered to detect associations with common genetic variations, we couldn’t replicate the previously identified GWAS SNPs conducted in adults, which could be for example attributable to absence of power to detect less common SNPs or SNPs with small effects, to differences in linkage disequilibrium, age group structure or the analytical methods across studies105. However, the greater impact of FTO variants in children as compared to adults is well known106,107, and therefore the association of the FTO variants in childhood MetS etiology, not observed by GWAS of the adult population, implies the involvement of different SNPs at different age groups.

In conclusion, the results from the present study along with the comprehensive meta-analysis advance etiologic understanding of childhood MetS, highlight that the genetic predisposition to MetS is largely driven by genes of obesity and lipid metabolism. Future work on functional characterization will further help in understanding the biological underpinnings underlying long-term MetS regulation. Our observation of distinct associations of variants of FTO and CETP for different component traits of MetS in children, suggests devising polygenic scores for MetS which may prove to be fundamental for identifying children and subsequently adults of the high-risk group to allow earlier targeted interventions.

Data availability

The authors declare that the data supporting the findings of this study are available within the article and its Supplementary Information files.


  1. 1.

    Alberti, K. G. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640–1645, (2009).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Grundy, S. M. Metabolic syndrome pandemic. Arteriosclerosis, thrombosis, Vasc. Biol. 28, 629–636, (2008).

    CAS  Article  Google Scholar 

  3. 3.

    Henneman, P. et al. Genetic architecture of plasma adiponectin overlaps with the genetics of metabolic syndrome-related traits. Diabetes Care 33, 908–913, (2010).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Monda, K. L. et al. The genetics of obesity and the metabolic syndrome. Endocr. Metab. Immune Disord. Drug. Targets 10, 86–108 (2010).

    CAS  Article  Google Scholar 

  5. 5.

    Lee, H. S., Kim, Y. & Park, T. New Common and Rare Variants Influencing Metabolic Syndrome and Its Individual Components in a Korean Population. Sci. Rep. 8, 5701, (2018).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Jeong, S. W., Chung, M., Park, S. J., Cho, S. B. & Hong, K. W. Genome-wide association study of metabolic syndrome in koreans. Genomics Inf. 12, 187–194, (2014).

    Article  Google Scholar 

  7. 7.

    Zhu, Y. et al. Susceptibility loci for metabolic syndrome and metabolic components identified in Han Chinese: a multi-stage genome-wide association study. J. Cell Mol. Med. 21, 1106–1116, (2017).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Kristiansson, K. et al. Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ. Cardiovasc. Genet. 5, 242–249, (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    McGarry, J. D. Banting Lecture 2001. Dysregulation Fat. Acid. Metab. Etiology Type 2 Diabetes 51, 7–18, (2002).

    CAS  Article  Google Scholar 

  10. 10.

    Kraja, A. T. et al. A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes 60, 1329–1339, (2011).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Aguilera, C. M., Olza, J. & Gil, A. Genetic susceptibility to obesity and metabolic syndrome in childhood. Nutr. Hosp. 28(Suppl 5), 44–55, (2013).

    CAS  Article  PubMed  Google Scholar 

  12. 12.

    Penas-Steinhardt, A. et al. Association of common variants in JAK2 gene with reduced risk of metabolic syndrome and related disorders. BMC Med. Genet. 12, 166, (2011).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Hou, H. et al. Association between Six CETP Polymorphisms and Metabolic Syndrome in Uyghur Adults from Xinjiang, China. Int J Environ Res Public Health 14, (2017).

  14. 14.

    Cahua-Pablo, J. A. et al. Polymorphisms in the LPL and CETP Genes and Haplotype in the ESR1 Gene Are Associated with Metabolic Syndrome in Women from Southwestern Mexico. Int. J. Mol. Sci. 16, 21539–21554, (2015).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Al-Hamad, D. & Raman, V. Metabolic syndrome in children and adolescents. Transl. pediatrics 6, 397–407, (2017).

    Article  Google Scholar 

  16. 16.

    Ahrens, W. et al. Cohort Profile: The transition from childhood to adolescence in European children–how I.Family extends the IDEFICS cohort. Int. J. Epidemiol. 46, 1394–1395j, (2017).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Ahrens, W. et al. The IDEFICS cohort: design, characteristics and participation in the baseline survey. Int. J. Of. Obes. 35, S3, (2011).

    Article  Google Scholar 

  18. 18.

    Ahrens, W. et al. Metabolic syndrome in young children: definitions and results of the IDEFICS study. Int. J. Obes. 38, S4–S14, (2014).

    Article  Google Scholar 

  19. 19.

    Weale, M. E. Quality control for genome-wide association studies. Methods Mol. Biol. 628, 341–372, (2010).

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Ziegler, A. Genome-wide association studies: quality control and population-based measures. Genet. Epidemiol. 33(Suppl 1), S45–S50, (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Aulchenko, Y. S., Ripke, S., Isaacs, A. & van Duijn, C. M. GenABEL: an R library for genome-wide association analysis. Bioinformatics 23, 1294–1296, (2007).

    CAS  Article  PubMed  Google Scholar 

  22. 22.

    Zheng, X. et al. A high-performance computing toolset for relatedness and principal component analysis of SNP data. Bioinformatics 28, 3326–3328, (2012).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  23. 23.

    MacArthur, J. et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic acids Res. 45, D896–D901, (2017).

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    Tawfik, N. S. & Spruit, M. R. The SNPcurator: literature mining of enriched SNP-disease associations. Database: J. Biol. databases curation 2018, bay020, (2018).

    Article  Google Scholar 

  25. 25.

    Piñero, J. et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic acids Res. 45, D833–D839, (2017).

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Davis, A. P. et al. The Comparative Toxicogenomics Database: update 2019. Nucleic Acids Res, (2018).

  27. 27.

    Xu, Z. & Taylor, J. A. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic acids Res. 37, W600–W605, (2009).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  28. 28.

    Wells, G. A. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, (2011).

  29. 29.

    Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G. & Group, P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6, e1000097–e1000097, (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  30. 30.

    Chen, H. et al. Control for Population Structure and Relatedness for Binary Traits in Genetic Association Studies via Logistic Mixed Models. Am. J. Hum. Genet. 98, 653–666, (2016).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  31. 31.

    Pruim, R. J. et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26, 2336–2337, (2010).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  32. 32.

    Consortium, G. T. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580–585, (2013).

    CAS  Article  Google Scholar 

  33. 33.

    Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310–315, (2014).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  34. 34.

    Boyle, A. P. et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 22, 1790–1797, (2012).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Graffelman, J. Exploring Diallelic Genetic Markers: The HardyWeinberg Package. Journal of Statistical Software 064 (2015).

  36. 36.

    Higgins, J. P. T., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ 327, 557–560, (2003).

    Article  PubMed  PubMed Central  Google Scholar 

  37. 37.

    Peters, J. L., Sutton, A. J., Jones, D. R., Abrams, K. R. & Rushton, L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J. Clin. Epidemiol. 61, 991–996, (2008).

    Article  PubMed  Google Scholar 

  38. 38.

    Egger, M., Smith, G. D., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–634, (1997).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Ahmad, T. et al. The fat-mass and obesity-associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women. Am. Heart J. 160, 1163–1169, (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  40. 40.

    Armamento-Villareal, R. et al. The FTO gene is associated with a paradoxically favorable cardiometabolic risk profile in frail, obese older adults. Pharmacogenet Genomics 26, 154–160, (2016).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Attaoua, R. et al. Association of the FTO gene with obesity and the metabolic syndrome is independent of the IRS-2 gene in the female population of Southern France. Diabetes Metab. 35, 476–483, (2009).

    CAS  Article  PubMed  Google Scholar 

  42. 42.

    Attaoua, R. et al. FTO gene associates to metabolic syndrome in women with polycystic ovary syndrome. Biochemical Biophysical Res. Commun. 373, 230–234, (2008).

    CAS  Article  Google Scholar 

  43. 43.

    Baik, I. & Shin, C. Interactions between the FTO rs9939609 polymorphism, body mass index, and lifestyle-related factors on metabolic syndrome risk. Nutr 6, 78–85, (2012).

    CAS  Article  Google Scholar 

  44. 44.

    Chedraui, P. et al. Polymorphisms of the FTO and MTHFR genes and vascular, inflammatory and metabolic marker levels in postmenopausal women. J. Endocrinol. Invest. 39, 885–890, (2016).

    CAS  Article  PubMed  Google Scholar 

  45. 45.

    Col, N., Demircioglu-Kilic, B., Nacak, M. & Araz, M. Adolescent obesity and the role of the fat mass and obesity-associated gene polymorphism. Clin. Invest. Med. 40, E235–E242, (2017).

    Article  PubMed  Google Scholar 

  46. 46.

    de Luis, D. A. et al. Relation of the rs9939609 gene variant in FTO with metabolic syndrome in obese female patients. J. Diabetes Complications 27, 346–350, (2013).

    Article  PubMed  Google Scholar 

  47. 47.

    Dusatkova, L. et al. Association of obesity susceptibility gene variants with metabolic syndrome and related traits in 1,443 Czech adolescents. Folia Biol. 59, 123–133 (2013).

    CAS  Google Scholar 

  48. 48.

    Elouej, S. et al. Association of genetic variants in the FTO gene with metabolic syndrome: A case-control study in the Tunisian population. J. Diabetes Complications 30, 206–211, (2016).

    Article  PubMed  Google Scholar 

  49. 49.

    Fawwad, A., Siddiqui, I. A., Zeeshan, N. F., Shahid, S. M. & Basit, A. Association of SNP rs9939609 in FTO gene with metabolic syndrome in type 2 diabetic subjects, rectruited from a tertiary care unit of Karachi, Pakistan. Pak 31, 140–145, (2015).

    Article  Google Scholar 

  50. 50.

    Freathy, R. M. et al. Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes 57, 1419–1426, (2008).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  51. 51.

    Hotta, K. et al. Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population. J. Hum. Genet. 56, 647–651, (2011).

    CAS  Article  PubMed  Google Scholar 

  52. 52.

    Liem, E. T. et al. Influence of common variants near INSIG2, in FTO, and near MC4R genes on overweight and the metabolic profile in adolescence: the TRAILS (TRacking Adolescents’ Individual Lives Survey) Study. Am. J. Clin. Nutr. 91, 321–328, (2010).

    CAS  Article  PubMed  Google Scholar 

  53. 53.

    Liguori, R. et al. The FTO gene polymorphism (rs9939609) is associated with metabolic syndrome in morbidly obese subjects from southern Italy. Mol. Cell Probes 28, 195–199, (2014).

    CAS  Article  PubMed  Google Scholar 

  54. 54.

    Malgorzata, S. et al. Searching for Factors Raising the Incidence of Metabolic Syndrome Among 45-60-Year-Old Women. Aging dis. 9, 831–842, (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  55. 55.

    Petkeviciene, J. et al. Physical activity, but not dietary intake, attenuates the effect of the FTO rs9939609 polymorphism on obesity and metabolic syndrome in Lithuanian adult population. Public. Health 135, 23–29, (2016).

    CAS  Article  PubMed  Google Scholar 

  56. 56.

    Phillips, C. M. et al. High dietary saturated fat intake accentuates obesity risk associated with the fat mass and obesity-associated gene in adults. J. Nutr. 142, 824–831, (2012).

    CAS  Article  PubMed  Google Scholar 

  57. 57.

    Ramos, R. B. & Spritzer, P. M. FTO gene variants are not associated with polycystic ovary syndrome in women from Southern Brazil. Gene 560, 25–29, (2015).

    CAS  Article  PubMed  Google Scholar 

  58. 58.

    Ranjith, N., Pegoraro, R. J. & Shanmugam, R. Obesity-associated genetic variants in young Asian Indians with the metabolic syndrome and myocardial infarction. Cardiovasc. J. Afr. 22, 25–30, (2011).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  59. 59.

    Reynolds, G. P. et al. The obesity risk gene FTO influences body mass in chronic schizophrenia but not initial antipsychotic drug-induced weight gain in first-episode patients. Int. J. Neuropsychopharmacol. 16, 1421–1425, (2013).

    CAS  Article  PubMed  Google Scholar 

  60. 60.

    Rodrigues, G. K. et al. A single FTO gene variant rs9939609 is associated with body weight evolution in a multiethnic extremely obese population that underwent bariatric surgery. Nutrition 31, 1344–1350, (2015).

    CAS  Article  PubMed  Google Scholar 

  61. 61.

    Sedaghati-Khayat, B. et al. Lack of association between FTO gene variations and metabolic healthy obese (MHO) phenotype: Tehran Cardio-metabolic Genetic Study (TCGS). Eat. Weight. Disorders: EWD 10, 10, (2018).

    Article  Google Scholar 

  62. 62.

    Sikhayeva, N. et al. Association between 28 single nucleotide polymorphisms and type 2 diabetes mellitus in the Kazakh population: a case-control study. BMC Med. Genet. 18, 76, (2017).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  63. 63.

    Sjogren, M. et al. The search for putative unifying genetic factors for components of the metabolic syndrome. Diabetologia 51, 2242–2251, (2008).

    CAS  Article  PubMed  Google Scholar 

  64. 64.

    Slezak, R., Leszczynski, P., Warzecha, M., Laczmanski, L. & Misiak, B. Assessment of the FTO gene polymorphisms in male patients with metabolic syndrome. Adv 27, 1581–1585, (2018).

    Article  Google Scholar 

  65. 65.

    Steemburgo, T. et al. The rs7204609 polymorphism in the fat mass and obesity-associated gene is positively associated with central obesity and microalbuminuria in patients with type 2 diabetes from Southern Brazil. J. Ren. Nutr. 22, 228–236, (2012).

    CAS  Article  PubMed  Google Scholar 

  66. 66.

    Tabara, Y. et al. Prognostic significance of FTO genotype in the development of obesity in Japanese: the J-SHIPP study. Int. J. Obes. 33, 1243–1248, (2009).

    CAS  Article  Google Scholar 

  67. 67.

    Vankova, D., Radanova, M., Kiselova-Kaneva, Y., Madjova, V. & Ivanova, D. The fto rs9939609, adipoq rs1501299, rs822391, and adipor2 rs16928662 polymorphisms relationship to obesity and metabolic syndrome in bulgarian sample. Biotechnol. Biotechnol. Equip. 26, 65–71, (2012).

    Article  Google Scholar 

  68. 68.

    Wang, T. et al. The association between common genetic variation in the FTO gene and metabolic syndrome in Han Chinese. Chin. Med. J. 123, 1852–1858 (2010).

    CAS  PubMed  Google Scholar 

  69. 69.

    Zhao, X. et al. An obesity genetic risk score is associated with metabolic syndrome in Chinese children. Gene 535, 299–302, (2014).

    CAS  Article  PubMed  Google Scholar 

  70. 70.

    Al-Attar, S. A. et al. Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample. Cardiovascular Diabetology 7, (2008).

  71. 71.

    Cheung, C. Y. et al. Genetic variants associated with persistent central obesity and the metabolic syndrome in a 12-year longitudinal study. Eur. J. Endocrinol. 164, 381–388, (2011).

    CAS  Article  PubMed  Google Scholar 

  72. 72.

    Cruz, M. et al. Candidate gene association study conditioning on individual ancestry in patients with type 2 diabetes and metabolic syndrome from Mexico City. Diabetes Metab. Res. Rev. 26, 261–270, (2010).

    CAS  Article  PubMed  Google Scholar 

  73. 73.

    Elouej, S. et al. Association of rs9939609 Polymorphism with Metabolic Parameters and FTO Risk Haplotype Among Tunisian Metabolic Syndrome. Metab. Syndr. Relat. Disord. 14, 121–128, (2016).

    CAS  Article  PubMed  Google Scholar 

  74. 74.

    Guclu-Geyik, F. et al. Risk of obesity and metabolic syndrome associated with FTO gene variants discloses clinically relevant gender difference among Turks. Mol. Biol. Rep. 43, 485–494, (2016).

    CAS  Article  PubMed  Google Scholar 

  75. 75.

    Hu, Y. H. et al. Association between polymorphisms of fat mass and obesity-associated gene and metabolic syndrome in Kazakh adults of Xinjiang, China. Genet. Mol. Res. 14, 14597–14606, (2015).

    CAS  Article  PubMed  Google Scholar 

  76. 76.

    Khella, M. S., Hamdy, N. M., Amin, A. I. & El-Mesallamy, H. O. The (FTO) gene polymorphism is associated with metabolic syndrome risk in Egyptian females: a case- control study. BMC Med. Genet. 18, 101, (2017).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  77. 77.

    Rotter, I. et al. Relationships between FTO rs9939609, MC4R rs17782313, and PPARgamma rs1801282 polymorphisms and the occurrence of selected metabolic and hormonal disorders in middle-aged and elderly men - a preliminary study. Clin. Interv. Aging 11, 1723–1732, (2016).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  78. 78.

    Hasan, H. A., AbuOdeh, R. O., Muda, W., Mohamed, H. & Samsudin, A. R. Association of Vitamin D receptor gene polymorphisms with metabolic syndrome and its components among adult Arabs from the United Arab Emirates. Diabetes Metab. Syndr. 11(Suppl 2), S531–S537, (2017).

    Article  PubMed  Google Scholar 

  79. 79.

    Larder, R., Cheung, M. K., Tung, Y. C., Yeo, G. S. & Coll, A. P. Where to go with FTO? Trends Endocrinol. metabolism: TEM. 22, 53–59, (2011).

    CAS  Article  PubMed  Google Scholar 

  80. 80.

    Gerken, T. et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318, 1469–1472, (2007).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  81. 81.

    Javierre, B. M. et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res. 20, 170–179, (2010).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  82. 82.

    Campión, J., Milagro, F. I. & Martínez, J. A. Individuality and epigenetics in obesity. Obes. Rev. 10, 383–392, (2009).

    CAS  Article  PubMed  Google Scholar 

  83. 83.

    Mizuno, T. M. Fat Mass and Obesity Associated (FTO) Gene and Hepatic Glucose and Lipid Metabolism. Nutrients 10, 1600, (2018).

    CAS  Article  PubMed Central  Google Scholar 

  84. 84.

    Smemo, S. et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507, 371–375, (2014).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  85. 85.

    Zou, Y. et al. IRX3 Promotes the Browning of White Adipocytes and Its Rare Variants are Associated with Human Obesity Risk. EBioMedicine 24, 64–75, (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  86. 86.

    Basile, K. J., Johnson, M. E., Xia, Q. & Grant, S. F. A. Genetic susceptibility to type 2 diabetes and obesity: follow-up of findings from genome-wide association studies. Int. J. Endocrinol. 2014, 769671–769671, (2014).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  87. 87.

    Kilpelainen, T. O. et al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat. Genet. 43, 753–760, (2011).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  88. 88.

    Wang, Q. et al. Relationship between fat mass and obesity-associated gene expression and type 2 diabetes mellitus severity. Exp. Ther. Med. 15, 2917–2921, (2018).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  89. 89.

    Frayling, T. M. et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889–894, (2007).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  90. 90.

    Lauria, F. et al. Prospective analysis of the association of a common variant of FTO (rs9939609) with adiposity in children: results of the IDEFICS study. PLoS one 7, e48876–e48876, (2012).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  91. 91.

    Hertel, J. K. et al. FTO, type 2 diabetes, and weight gain throughout adult life: a meta-analysis of 41,504 subjects from the Scandinavian HUNT, MDC, and MPP studies. Diabetes 60, 1637–1644, (2011).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  92. 92.

    Zabena, C. et al. The FTO obesity gene. Genotyping and gene expression analysis in morbidly obese patients. Obes. Surg. 19, 87–95, (2009).

    Article  PubMed  Google Scholar 

  93. 93.

    Al-Attar, S. A. et al. Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample. Cardiovasc. Diabetol. 7, 5, (2008).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  94. 94.

    Povel, C. M., Boer, J. M., Reiling, E. & Feskens, E. J. Genetic variants and the metabolic syndrome: a systematic review. Obes. Rev. 12, 952–967, (2011).

    CAS  Article  PubMed  Google Scholar 

  95. 95.

    Frisdal, E. et al. Functional interaction between −629C/A, −971G/A and −1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study. Hum. Mol. Genet. 14, 2607–2618, (2005).

    CAS  Article  PubMed  Google Scholar 

  96. 96.

    Lu, H. et al. Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism. J. Mol. Med. 81, 246–255, (2003).

    CAS  Article  PubMed  Google Scholar 

  97. 97.

    Boekholdt, S. M. et al. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation 111, 278–287, (2005).

    CAS  Article  PubMed  Google Scholar 

  98. 98.

    O’Neill, S. & O’Driscoll, L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes. Rev. 16, 1–12, (2015).

    Article  PubMed  Google Scholar 

  99. 99.

    Heindel, J. J. et al. Metabolism disrupting chemicals and metabolic disorders. Reprod. Toxicol. 68, 3–33, (2017).

    CAS  Article  PubMed  Google Scholar 

  100. 100.

    Wang, H., Dong, S., Xu, H., Qian, J. & Yang, J. Genetic variants in FTO associated with metabolic syndrome: a meta- and gene-based analysis. Mol. Biol. Rep. 39, 5691–5698, (2012).

    CAS  Article  PubMed  Google Scholar 

  101. 101.

    Fall, T. et al. The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis. PLoS Medicine/Public Library Sci. 10, e1001474, (2013).

    Article  Google Scholar 

  102. 102.

    Zhou, D. et al. Common variant (rs9939609) in the FTO gene is associated with metabolic syndrome. Mol. Biol. Rep. 39, 6555–6561, (2012).

    CAS  Article  PubMed  Google Scholar 

  103. 103.

    Qi, L. et al. Fat mass-and obesity-associated (FTO) gene variant is associated with obesity: longitudinal analyses in two cohort studies and functional test. Diabetes 57, 3145–3151, (2008).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  104. 104.

    Kelishadi, R., Hovsepian, S. & Javanmard, S. H. A Systematic review of single nucleotide polymorphisms associated with metabolic syndrome in children and adolescents. children 29, 46 (2017).

    Google Scholar 

  105. 105.

    Kraft, P., Zeggini, E. & Ioannidis, J. P. A. Replication in genome-wide association studies. Stat. Sci. 24, 561–573, (2009).

    MathSciNet  Article  PubMed  PubMed Central  MATH  Google Scholar 

  106. 106.

    Graff, M. et al. BMI loci and longitudinal BMI from adolescence to young adulthood in an ethnically diverse cohort. Int. J. Obes. 41(2005), 759–768, (2017).

    CAS  Article  Google Scholar 

  107. 107.

    Hardy, R. et al. Life course variations in the associations between FTO and MC4R gene variants and body size. Hum. Mol. Genet. 19, 545–552, (2010).

    CAS  Article  PubMed  Google Scholar 

Download references


This work was done as part of the IDEFICS/I.Family studies. We gratefully acknowledge the financial support of the European Commission within the Sixth RTD Framework Programme Contract No. 016181 (FOOD), and the Seventh RTD Framework Programme Contract No. 266044. The publication of this article was partially funded by the Open Access Fund of the Leibniz Association. We thank the IDEFICS and I.Family children and their parents for taking the time to participate in this extensive examination program. The funding sources had no role in the design, conduct, and analysis of the study or in the decision to submit the manuscript for publication.We are grateful for the support provided by school boards, headmasters, teachers, school staff and communities, and for the effort of all study nurses and our data managers, especially Claudia Brünings-Kuppe, Willempje Hummel-Bartenschlager, and Sandra Israel-Georgii.

Author information




R.N. and R.F. contributed to the association analysis of the genotyping data. R.N. and M.M. contributed to the large-scale epidemiologic analysis. R.N., R.F. and M.M. drafted the paper. R.N., R.F., F.G., L.I., S.M., N.M., D.M., L.M., P.R., T.V., W.A. and M.M. provided critical comments on the paper, draft, and analysis. All authors read and approved the final paper.

Corresponding author

Correspondence to Rajini Nagrani.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nagrani, R., Foraita, R., Gianfagna, F. et al. Common genetic variation in obesity, lipid transfer genes and risk of Metabolic Syndrome: Results from IDEFICS/I.Family study and meta-analysis. Sci Rep 10, 7189 (2020).

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing